Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene
- William W. Au(corresponding author),
- Salama Abdou-Salama,
- Ayman Al-Hendy
- University of Texas Medical Branch at Galveston
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Objective.: Estrogen stimulates human papilloma virus oncogene expression, promotes cervical cancer (CC) cell proliferation and prevents apoptosis. Therefore, blockage of estrogen function may have therapeutic application to CC. Methods.: CasKi CC cells were transfected with an adenovirus expressing a dominant negative estrogen receptor gene (Ad-ER-DN) and their responses were investigated by RT-PCR, Flow Cytometry and Western blot assays. Result.: Transfected cells showed disturbance of cell colony morphology, reduced HPV E6 and E7 mRNA, interruption of cell proliferation, reduced cyclin D1 protein and expression of apoptosis. Conclusion.: We report, for the first time, the use of Ad-ER-DN to block estrogen receptors which led to dramatic changes in CC cells that are consistent with the possible reactivation of cellular p53 and Rb function. Their reactivation most likely allowed the recognition of existing chromosome abnormalities as a serious stress signal and the initiation of a cascade of cellular events in response to the stress, including the activation of the core apoptotic machinery which led to self-destruction of the CC cells.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 276-280 (5 pages)Journal (Volume, Issue Number)
Gynecologic Oncology (Volume 104, Issue 2)Publication milestones
- Published - 02/2007
Publication status
ISSN
0090-8258Publication IDs
- Scopus: 33846377598
- PubMed: 17137618
